Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – Improvements in the treatment of cystic fibrosis (CF) during early childhood have led to fewer infections with Pseudomonas aeruginosa and stable lung function…
NEW YORK (Reuters Health) – If an initial screening colonoscopy indicates no colorectal neoplasia, the odds that a malignancy will develop in the next 5 years is “extremely…
NEW YORK (Reuters Health) – Hospitalization rates for angioedema have increased in the United States in recent years, surpassing those for other allergic disorders in 2001, according to…
NEW YORK (Reuters Health) – In hypertensive patients with a prior MI, a treatment strategy based on sustained release verapamil is comparable to one based on atenolol in…
NEW YORK (Reuters Health) – Exposure to bisphenol A (BPA), a chemical used in the resins that line food and beverage containers and in the production of polycarbonate…
NEW YORK (Reuters Health) – Treatment with the phosphodiesterase inhibitor pentoxifylline can significantly reduce proteinuria in patients with diabetic and other forms of chronic kidney disease, according to…
NEW YORK (Reuters Health) – Women with inadequately treated asthma during pregnancy are at increased risk for premature delivery, according to findings by the Organization of Teratology Information…
NEW YORK (Reuters Health) – Findings from a new study suggest that contrary to what some researchers have hypothesized, migraine is not associated with atherosclerosis, but it may…
NEW YORK (Reuters Health) – In elderly patients with rheumatoid arthritis, treatment with tumor necrosis factor (TNF)-alpha antagonists may increase their risk of new-onset heart failure, and exacerbate…
NEW YORK (Reuters Health) – Gastric acid suppression by proton pump inhibitors (PPIs) is associated with an increased risk of Clostridium difficile-related diarrhea in hospitalized patients, results of…
